twitter logo youtube logo

Management of osteoporosis and the prevention of fragility fractures


Osteoporosis is a common bone disease characterised by reduced bone mass which is associated with an increased risk of low trauma fractures. Fractures are an important cause of morbidity, and patients who suffer hip and vertebral fractures have a decreased life expectancy.

Remit and target users

This guideline provides recommendations based on current evidence for best practice in the management of osteoporosis and prevention of fractures. It addresses risk factors for fracture, commonly-used tools for fracture risk assessment, approaches to targeting therapy, pharmacological, and non-pharmacological treatments to reduce fracture risk in different patient groups, treatment of painful vertebral fractures and systems of care. The assessment and prevention of falls and surgical management of fractures is not included.

How this guideline was developed

This guideline was developed using a standard methodology based on a systematic review of the evidence. Further details can be found in SIGN 50: A Guideline Developer’s Handbook.

Keeping up to date

This guideline was issued in 2015 and will be considered for review in three years. The review history, and any updates to the guideline in the interim period, will be noted in the review report.

If you are aware of any new evidence that would update this guideline please complete a change request form  and return to:

Current < 3 years

guidelines international network logo


HIS Healthcare Improvement Scotland logo